Compare EXEL & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | EPAM |
|---|---|---|
| Founded | 1994 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.5B |
| IPO Year | 2000 | 2011 |
| Metric | EXEL | EPAM |
|---|---|---|
| Price | $41.26 | $136.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | $46.45 | ★ $201.07 |
| AVG Volume (30 Days) | ★ 2.8M | 1.5M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | N/A |
| EPS | 2.78 | ★ 6.72 |
| Revenue | $452,477,000.00 | ★ $1,450,448,000.00 |
| Revenue This Year | $13.66 | $8.50 |
| Revenue Next Year | $13.73 | $7.35 |
| P/E Ratio | ★ $14.80 | $20.19 |
| Revenue Growth | N/A | ★ 25.02 |
| 52 Week Low | $32.38 | $125.57 |
| 52 Week High | $48.74 | $222.53 |
| Indicator | EXEL | EPAM |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 33.17 |
| Support Level | $40.01 | $125.57 |
| Resistance Level | $44.15 | $148.34 |
| Average True Range (ATR) | 1.33 | 5.61 |
| MACD | -0.16 | 1.91 |
| Stochastic Oscillator | 26.06 | 49.78 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.